FABTECH: Fabtech Technologies Limited has informed the Exchange regarding a press release dated November 03, 2025, titled "Fabtech Technologies Limited Secures ₹52 Crore Contract to Build Next-Generation Veterinary Formulations Facility in North Africa".
FABTECH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fabtech Technologies Limited (FTL) has won a ₹52 crore turnkey contract to set up a veterinary medicines manufacturing facility in the Maghreb region of North Africa. The project covers complete design, engineering, cleanroom systems, utilities, and process equipment for a modern veterinary dosage plant. With this new order, the company's cumulative order book has risen to ₹983.05 crore, strengthening revenue visibility. The company highlighted that the veterinary formulations market in the Maghreb is expected to reach USD 500–700 million by 2030, driven by rising demand for livestock and companion animal health products.
This is a positive development — a new international order boosts the order book to nearly ₹983 crore and signals continued expansion into high-growth markets beyond India. Shareholders may view this as a sign of healthy international demand and improving business momentum, though execution and geopolitical risks in North Africa remain factors to watch.